Company Overview and News
Sustainability has become a bit of a buzzword in recent months, used in everything from fashion to tourism. According to the Brundtland Report, sustainability is “development that meets the needs of the present without compromising the ability of future.” But what does that mean in business practice? And how can today’s current generation of pioneers use it to build the future of business?
FPHPC EGDCY EDC 532219 FPHP ENERGYDEV FPH
THE PHILIPPINE STOCK EXCHANGE index (PSEi) exited bear territory on Friday amid what one analyst described as “a dizzying rally”, but its strong recovery was not enough to prevent its third straight week-on-week drop.
FPHPC MPCIY BDOUY AYAAY UVRBY AEV FPHP DD SECB MRAIF BDOUF BDO ABTZY MPI MPCFF SYBJF URC MRC ALI FPH UVRBF AYAAF
Clockwise from left: Marimel Francisco, Zarah Juan, Bae Arlyn Salazar, Maritess Pineda, Cedie Vargas, Mita Rufino, Suzy Quiros with the Bagobo Tagabawa community
FPHPC FPHP FPH
LOPEZ Holdings Corp. reported a net income of P1.03 billion in the second quarter, higher by 43% compared with year ago’s P721-million profit attributable to the equity holders of the parent firm, with the stable showing of its energy unit boosting the quarterly results.
FPHPC FSGCF FGENG FGENF MER FGEN FSGCY LPZ FPHP FPH
Lopez Holdings Corp. reported a net income of P1.03 billion in the second quarter, higher by 43% compared with year ago’s P721-million profit attributable to the equity holders of the parent firm, with the stable showing of its energy unit boosting the quarterly results.
FPHPC FSGCF FGENG FGENF FGEN FSGCY LPZ FPHP FPH
The Joint Foreign Chambers of Commerce of the Philippines (JFC) will host two major events this year: the Seventh Anniversary Arangkada Philippines Forum entitled “Better Infrastructure for a Strong Economy” and a special Creative Industries Forum entitled “Creative Industries: The Next Sunrise Industry.”
FPHPC MWC MPCFF MPCIY MWP MPI FPHP MWIDE FPH
2018-05-28 bworldonline - 1
LOPEZ-LED First Philippine Holdings Corp. (FPH) is setting aside a budget of P22 billion for 2018, with its property development segment cornering the bulk of the capital expenditures, the company treasurer said on Monday.
FSGCF FGENG FGENF FGEN FSGCY FPH
Conglomerate Lopez Holdings posted a net profit of P4.22 billion last year, down by 36 percent in the absence of one-off gains and election season-related surge in media advertising revenue that jacked up its bottom line in 2016.
FPHPC FSGCF FGENG FGENF FGEN FSGCY LPZ FPHP FPH
Conglomerate Lopez Holdings chalked up a net profit of P4.22 billion last year, down by 36 percent in the absence of one-off gains and election season-related surge in media advertising revenues that jacked up earnings in 2016.
FPHPC FSGCF FGENG FGENF FGEN FSGCY FPHP FPH
FIRST Philippine Holdings Corp. (FPH) reported on Friday a 15% increase in 2017 net profit on a recurring basis to P6.8 billion, which excludes a one-off item in connection with debt prepayments by unit First Gen Corp.
FPHPC EGDCY FSGCY 532219 FPHP ENERGYDEV FSGCF FGENG FGENF FGEN EDC FPH
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to PSE:FPH / First Philippine Holdings Corporation on message board site Silicon Investor.
|Fountain Pharmaceuticals (FPHI)||Fountain Pharmaceuticals (FPHI)||Fountain Pharmaceuticals (FPHI)|